Swiss-Chinese Life Sciences Forum 2017

Swiss-Chinese Life Sciences Forum 2017


Chinese Pharma Goes Global

The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss-Chinese Life Sciences Forum 2018 is organised by, the Fachhochschule Nordwestschweiz, the Swiss Chinese Chamber of Commerce and hosted by Novartis.

The event with the title “Chinese Pharma Goes Global” will open its doors on 13 September 2018 from 1.30 to 5.30 pm at the Novartis Campus in Basel. Tickets are 80 Swiss Francs per person.

John Oyler - CEO and Founder of BeiGene
Nigel Sheail - Head, Mergers & Acquisitions and Business Development & Licensing, Novartis International AG
Sammy Jiang - VP, Strategy & International Business, Luye Pharma Group
Larry Zhang - VP, Head of Public Affairs & CSR, Novartis China
Tobias Valk – Partner, Head of Deal Advisory, KPMG Switzerland
Asymchem (tbd)

For more information and to register, please visit:

This event is ...

hosted by: Novartis
sponsored by: KPMG Switzerland, Asymchem, Canton of Basel-Stadt.
organized by:, Swiss Chinese Chamber of Commerce, Fachhochschule Nordwestschweiz.


Life Sciences
Cookies uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.